CY2375B1 - Use of penciclorin for the treatment of post-therapeutic neuralgia. - Google Patents

Use of penciclorin for the treatment of post-therapeutic neuralgia.

Info

Publication number
CY2375B1
CY2375B1 CY0300059A CY0300059A CY2375B1 CY 2375 B1 CY2375 B1 CY 2375B1 CY 0300059 A CY0300059 A CY 0300059A CY 0300059 A CY0300059 A CY 0300059A CY 2375 B1 CY2375 B1 CY 2375B1
Authority
CY
Cyprus
Prior art keywords
penciclorin
post
treatment
therapeutic neuralgia
neuralgia
Prior art date
Application number
CY0300059A
Other languages
English (en)
Inventor
Ronald James Boon
David Ronald John Griffin
Original Assignee
Novartis Int Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26303637&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2375(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB939320485A external-priority patent/GB9320485D0/en
Priority claimed from GB939321255A external-priority patent/GB9321255D0/en
Application filed by Novartis Int Pharm Ltd filed Critical Novartis Int Pharm Ltd
Publication of CY2375B1 publication Critical patent/CY2375B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY0300059A 1993-10-05 2003-08-25 Use of penciclorin for the treatment of post-therapeutic neuralgia. CY2375B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939320485A GB9320485D0 (en) 1993-10-05 1993-10-05 Pharmaceuticals
GB939321255A GB9321255D0 (en) 1993-10-14 1993-10-14 Pharmaceuticals

Publications (1)

Publication Number Publication Date
CY2375B1 true CY2375B1 (en) 2004-06-04

Family

ID=26303637

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0300059A CY2375B1 (en) 1993-10-05 2003-08-25 Use of penciclorin for the treatment of post-therapeutic neuralgia.

Country Status (16)

Country Link
US (1) US5866581A (da)
EP (1) EP0804199B1 (da)
JP (1) JP3768527B2 (da)
CN (1) CN1082816C (da)
AP (1) AP616A (da)
AT (1) ATE216885T1 (da)
AU (1) AU7788494A (da)
CA (1) CA2173505C (da)
CY (1) CY2375B1 (da)
DE (1) DE69430545T2 (da)
DK (1) DK0804199T3 (da)
ES (1) ES2176258T3 (da)
HU (1) HU226472B1 (da)
IL (1) IL111138A (da)
PT (1) PT804199E (da)
WO (1) WO1995009632A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9600847D0 (en) 1996-01-16 1996-03-20 Smithkline Beecham Plc Pharmaceuticals
ATE279188T1 (de) * 1998-07-09 2004-10-15 Warner Lambert Co Pharmazeutische zusammensetzungen enthaltend gaba-analogen und ein antivirales mittel zur behandlung von herpes zoster
US6419934B1 (en) 1999-02-24 2002-07-16 Edward L. Tobinick TNF modulators for treating neurological disorders associated with viral infection
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
WO2013167743A1 (en) * 2012-05-11 2013-11-14 Akron Molecules Gmbh Use of compounds for the treatment of pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141927B1 (en) * 1983-08-18 1991-10-30 Beecham Group Plc Antiviral guanine derivatives
EP0182024B1 (en) * 1984-09-20 1991-04-03 Beecham Group Plc Purine derivatives and their pharmaceutical use

Also Published As

Publication number Publication date
EP0804199B1 (en) 2002-05-02
HUT74076A (en) 1996-10-28
HU226472B1 (en) 2008-12-29
ES2176258T3 (es) 2002-12-01
WO1995009632A1 (en) 1995-04-13
JPH10513434A (ja) 1998-12-22
CN1082816C (zh) 2002-04-17
ATE216885T1 (de) 2002-05-15
DE69430545T2 (de) 2002-11-07
HU9600882D0 (en) 1996-05-28
EP0804199A1 (en) 1997-11-05
AU7788494A (en) 1995-05-01
DE69430545D1 (de) 2002-06-06
AP9400684A0 (en) 1994-10-31
HK1004115A1 (en) 1998-11-20
CA2173505C (en) 2005-03-29
PT804199E (pt) 2002-09-30
IL111138A (en) 1997-04-15
JP3768527B2 (ja) 2006-04-19
CA2173505A1 (en) 1995-04-13
AP616A (en) 1997-09-15
IL111138A0 (en) 1994-12-29
US5866581A (en) 1999-02-02
CN1135180A (zh) 1996-11-06
DK0804199T3 (da) 2002-08-19

Similar Documents

Publication Publication Date Title
GR3022484T3 (en) Osteosynthesis aid.
ZA939161B (en) Wastewater treatment.
HU9503451D0 (en) The treatment of small animals
ZA942809B (en) Treatment
EP0661079A4 (en) MAGNETOTHERAPY APPARATUS.
EP0630383A4 (en) METHODS FOR TREATING DIABETIS.
GB2298196B (en) Water treatment
EP0622384A3 (de) Verfahren zur Herstellung von Polymerpolyesterolen.
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
CY2375B1 (en) Use of penciclorin for the treatment of post-therapeutic neuralgia.
EP0635482A3 (de) Verfahren zur Herstellung von mehrfach fluorierten Nitrobenzolen.
EP0609335A4 (en) Methods for the treatment of hyperlipidemia using azaspiranes.
GR3024856T3 (en) Process for the preparation of dichloroacetylchloride.
EP0635486A3 (de) Verfahren zur Herstellung von Fluorbenzonitrilen.
EP0635481A3 (de) Verfahren zur Herstellung von Fluornitrobenzolen.
EP0621264A3 (de) Verfahren zur Herstellung von 4-Alkanoaryl-benzylethern.
GB9407656D0 (en) Herbicidal treatment
SG49291A1 (en) Use of penciclorin for the treatment of post-therapeutic neuralgia
GB2275468B (en) Water treatment
ZA93348B (en) Treatment of liquids.
EP0662782A4 (en) THERAPY BASED ON PP14.
GB9317306D0 (en) Effluent treatment
EP0643123A3 (en) Process for the treatment of halogenated hydrocarbons.
GB2279070B (en) Process for the treatment of sewage
GB2306096B (en) The treatment of small animals